Search All News
Cardiovascular disease is the No. 1 cause of maternal mortality in the United States, but a new study suggests specialized cardio-obstetrics teams may improve outcomes.
People with congenital heart disease had a lower-than-expected risk for severe symptoms from COVID-19, a new study has found.
Columbia Nursing's Billy Caceres chaired a group that wrote the first American Heart Association Scientific Statement addressing LGBTQ heart health, published in the journal Circulation.
Heart transplants, donor hearts, and transplant waitlists all fell sharply at the start of the COVID-19 pandemic in the United States, Columbia University researchers have found.
- August 15, 2017
A new clinical trial will determine if the drug apixaban can prevent recurrent strokes in people with atrial cardiopathy.
- August 1, 2017
Aspirin does not increase the risk of hospitalization or death in patients taking ACE inhibitors or ARBs for heart failure, Columbia researchers have found.
- August 1, 2017
Using a noninvasive test developed at Columbia, older TAVR patients with an unusual heart failure pattern were found to have cardiac amyloidosis.
- May 1, 2017
Smoking counteracts the effect of a gene that normally protects against heart disease, according to a new study.
- March 6, 2017
Columbia University names cardiology researchers Muredach P. Reilly and Marwah Abdalla 2017 Marjorie and Lewis Katz Scholars.
- March 1, 2017
Researchers have found that only 16 percent of heart attack survivors get the recommended amount of physical activity in the weeks after hospitalization.
- January 20, 2017
A new study from Columbia University researchers estimates that 17 million Americans who have normal blood pressure in the doctor's office may have undiagnosed hypertension.
- December 20, 2016
Children who had heart surgery at NYP/CUMC had a significantly lower risk-adjusted mortality rate compared with all other New York state programs.
- December 9, 2016
Heart failure is no more common in individuals with sickle cell trait than in the general population, a new study has found.
- November 1, 2016
An international trial shows that TCEP, a procedure meant to reduce neurological complications, is safe for TAVR patients, though more research is needed on efficacy.